** Shares of biotech firm Hookipa Pharma HOOK.O up 70% at
$0.97 premarket
** Co says Gilead Sciences GILD.O has purchased 15 mln
shares of Hookipa's common stock for ~$21.25 mln at a price of
$1.42 per share
** Co says it has the right to sell an additional ~$8.75 mln
of common stock to Gilead as pro-rata participation in potential
future equity raises
** After the investment, GILD holds 19.4% of HOOK's common
shares, co says
** Shares of the $47.4 mln company have dropped 30% in value
this year
(Reporting by Medha Singh)
((medha.singh@thomsonreuters.com))